These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 30973809)

  • 1. Diabetic Cardiomyopathy.
    Dillmann WH
    Circ Res; 2019 Apr; 124(8):1160-1162. PubMed ID: 30973809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium Homeostasis in Ventricular Myocytes of Diabetic Cardiomyopathy.
    Al Kury LT
    J Diabetes Res; 2020; 2020():1942086. PubMed ID: 33274235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced reticulum-mitochondria Ca
    Dia M; Gomez L; Thibault H; Tessier N; Leon C; Chouabe C; Ducreux S; Gallo-Bona N; Tubbs E; Bendridi N; Chanon S; Leray A; Belmudes L; Couté Y; Kurdi M; Ovize M; Rieusset J; Paillard M
    Basic Res Cardiol; 2020 Nov; 115(6):74. PubMed ID: 33258101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart.
    Singh RM; Waqar T; Howarth FC; Adeghate E; Bidasee K; Singh J
    Heart Fail Rev; 2018 Jan; 23(1):37-54. PubMed ID: 29192360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular deformation associated with cardiomyocyte Ca(2+) transients delay in early stage of low-dose of STZ and high-fat diet induced type 2 diabetic rats.
    Liu XY; Liu FC; Deng CY; Zhang MZ; Yang M; Xiao DZ; Lin QX; Cai ST; Kuang SJ; Chen J; Chen SX; Zhu JN; Yang H; Rao F; Fu YH; Yu XY
    BMC Cardiovasc Disord; 2016 Feb; 16():41. PubMed ID: 26879576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options.
    Cieluch A; Uruska A; Zozulinska-Ziolkiewicz D
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial calcium handling and heart disease in diabetes mellitus.
    Diaz-Juarez J; Suarez JA; Dillmann WH; Suarez J
    Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165984. PubMed ID: 33002576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy.
    Ni R; Zheng D; Xiong S; Hill DJ; Sun T; Gardiner RB; Fan GC; Lu Y; Abel ED; Greer PA; Peng T
    Diabetes; 2016 Jan; 65(1):255-68. PubMed ID: 26470784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
    Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC
    J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell shortening and calcium dynamics in epicardial and endocardial myocytes from the left ventricle of Goto-Kakizaki type 2 diabetic rats.
    Smail M; Al Kury L; Qureshi MA; Shmygol A; Oz M; Singh J; Howarth FC
    Exp Physiol; 2018 Apr; 103(4):502-511. PubMed ID: 29363193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca
    Jaquenod De Giusti C; Palomeque J; Mattiazzi A
    Pflugers Arch; 2022 Jan; 474(1):33-61. PubMed ID: 34978597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium handling in the failing heart and SUMO--weighing the evidence.
    McMurray JJ; Smith GL
    N Engl J Med; 2011 Nov; 365(18):1738-9. PubMed ID: 22047567
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications.
    Kota SK; Kota SK; Jammula S; Panda S; Modi KD
    Diabetes Technol Ther; 2011 Nov; 13(11):1155-60. PubMed ID: 21751873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voltage dependence of the Ca
    Al Kury L; Sydorenko V; Smail MMA; Qureshi MA; Shmygol A; Oz M; Singh J; Howarth FC
    Mol Cell Biochem; 2018 Sep; 446(1-2):25-33. PubMed ID: 29318456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.
    Knapp M; Tu X; Wu R
    Acta Pharmacol Sin; 2019 Jan; 40(1):1-8. PubMed ID: 29867137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ins and outs of calcium in heart failure.
    O'Rourke B
    Circ Res; 2008 Jun; 102(11):1301-3. PubMed ID: 18535266
    [No Abstract]   [Full Text] [Related]  

  • 17. Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy.
    Mishra PK; Givvimani S; Metreveli N; Tyagi SC
    Biochem Biophys Res Commun; 2010 Oct; 401(2):175-81. PubMed ID: 20836991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on diabetic cardiomyopathy: inches forward, miles to go.
    Tillquist MN; Maddox TM
    Curr Diab Rep; 2012 Jun; 12(3):305-13. PubMed ID: 22528596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of excitation-contraction coupling in the heart: inhibition of sarcoplasmic reticulum Ca(2+) leak as a novel therapeutic approach.
    Neef S; Maier LS
    Curr Heart Fail Rep; 2007 Mar; 4(1):11-7. PubMed ID: 17386180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
    Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
    Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.